# EDGAR Filing Document

**Accession Number:** 0002069604
**File Stem:** 0002088869-25-000006
**Filing Date:** 2025-12
**Character Count:** 9745
**Document Hash:** d00e85a4cb41dc203506dc81c9c330d6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002088869-25-000006.hdr.sgml**: 20251202

**ACCESSION NUMBER**: 0002088869-25-000006

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251202

**FILED AS OF DATE**: 20251202

**DATE AS OF CHANGE**: 20251202

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Bernander Christopher James
- **CENTRAL INDEX KEY:** 0002089730

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42967
- **FILM NUMBER:** 251544355

**MAIL ADDRESS:**
- **STREET 1:** 8616 AMBERGATE DR
- **CITY:** VICTORIA
- **STATE:** MN
- **ZIP:** 55386
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Park Dental Partners, Inc.
- **CENTRAL INDEX KEY:** 0002069604
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 932020683
- **STATE OF INCORPORATION:** MN
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 2200 COUNTY ROAD C WEST
- **STREET 2:** SUITE 2210
- **CITY:** ROSEVILLE
- **STATE:** MN
- **ZIP:** 55113
- **BUSINESS PHONE:** 6516330500

**MAIL ADDRESS:**
- **STREET 1:** 2200 COUNTY ROAD C WEST
- **STREET 2:** SUITE 2210
- **CITY:** ROSEVILLE
- **STATE:** MN
- **ZIP:** 55113

## Ex-24

```

POWER OF ATTORNEY
The undersigned, in his or her capacity as a director or officer of Park Dental
Partners,
Inc. (the "Company"), constitutes and appoints Maxwell Black of Winthrop &
Weinstine, P.A.
as his or her true and lawful attorney-in-fact, with full power of
substitution, to:
(a) execute for and on behalf of the undersigned, in the undersigned's capacity
as a
director or officer of the Company, Forms 3, 4 and 5 (and any amendments
thereto) required to
be filed by the undersigned under Section 16 of the Securities Exchange Act of
1934, as
amended (the "Exchange Act"), and the rules and regulations thereunder;
(b) prepare, execute and file, for and on behalf of the undersigned, Schedules
13D and
13G (and any amendments thereto), together with any related exhibits, cover
pages, certifications
and documents, including any joint filing agreements, required to be filed by
the undersigned
under Section 13 of the Exchange Act, and the rules and regulations thereunder;
(c) prepare, execute and file for and on behalf of the undersigned electronic
Forms 144
(and any amendments thereto), together with any related certifications or
documents reasonably
necessary to effect such filings;
(d) prepare, execute and submit, on the undersigned's behalf, Form ID
applications,
updates, and renewals, and take any actions reasonably necessary to obtain,
maintain, recover or'
update Electronic Data Gathering, Analysis, and Retrieval ("EDGAR") access
credentials for the
undersigned, including Central Index Key ("CIK") assignment, access codes,
passphrases,
multi-factor authentication and role designations under EDGAR Next;
(e) cause the Company to accept a delegation of authority from any of the
undersigned's
EDGAR account administrators and, pursuant to that delegation, authorize the
Company's
EDGAR account administrators to appoint, remove or replace users for the
undersigned's
EDGAR account;
(f) do and perform any and all acts for and on behalf of the undersigned which
may be
necessary or desirable to complete, file and submit the foregoing documents
with the U.S.
Securities and Exchange Commission through the EDGAR system, including
coordinating with
the Company, its transfer agent, equity plan administrator, and brokers (each
as applicable) to
obtain holdings and transaction information, and preparing, submitting and
correcting any
amendments; and
(g) take any other action of any type whatsoever in connection with the
foregoing that, in
the opinion of such attorney-in-fact, may be of benefit to, in the best
interest of, or legally
required by, the undersigned, it being understood that the documents executed
by such
attorney-in-fact on behalf of the undersigned pursuant to this Power of
Attorney shall be in such
form and shall contain such terms and conditions as such attorney-in-fact may
approve in his
discretion consistent with the scope of authority granted herein.
The undersigned hereby grants to the attorney-in-fact full power and authority
to do and
perform any act necessary and proper to be done in the exercise of any of the
rights and powers
herein granted, as fully to all intents and purposes as the undersigned might
or could do
personally, with full power of substitution or revocation, hereby ratifying and
confirming all that
the attorney-in-fact, or his substitute or substitutes, shall lawfully do or
cause to be done by
virtue of this Power of Attorney and the rights and powers herein granted.
This Power of Attorney is limited to the purposes described above and does not
authorize
the attorney-in-fact to take any action on behalf of the undersigned other than
with respect to the
preparation, execution and filing of Schedules 13D and 13G, Forms 3, 4 and 5,
electronic Forms
144, and Form ID and associated EDGAR Next account administration, and actions
reasonably
incidental thereto (including the use and retention of electronic signatures
and approvals in
compliance with Regulation S-T). Nothing herein authorizes the attorney-in-fact
to make
investment decisions, execute trades, or direct the undersigned's brokerage
accounts. This Power
of Attorney shall remain in full force and effect until revoked by the
undersigned in a signed
writing delivered to the attorney-in-fact.
This Power of Attorney may be executed in counterparts, each of which shall be
deemed
an original, and all of which together shall constitute one and the same
instrument. Signatures
delivered by electronic transmission (including any electronic signature
compliant with
Regulation S-T) shall be deemed original for all purposes.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed
as of this 22nd day of October, 2025.
Signed by:
/s/ Christopher Bernander

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Bernander Christopher James<br><sub>(Last) (First) (Middle)</sub><br>2200 COUNTY ROAD C WEST<br>SUITE 2210<br><sub>(Street)</sub><br>ROSEVILLE, MN 55113<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Park Dental Partners, Inc. [ PARK ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2025-12-02 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Chief Financial Officer_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock<sup>(1)</sup> | 53833 | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) Includes 53,833 shares of restricted stock issued to the Reporting Person (the "Restricted Stock"), which shares vest as follows: (i) 25% on the completion of the Issuer's initial public offering; and (ii) thereafter, at the rate of 6.25% per quarter. The Restricted Stock is subject to accelerated vesting in connection with a change in control of the Issuer in accordance with the terms of the Park Dental Partners, Inc. 2023 Restricted Stock Plan and the applicable award agreement. The Restricted Stock does not confer any voting rights until the applicable shares have vested and the holder of Restricted Stock has become the record owner of such vested shares.

**Signature:** /s/ Maxwell Black as Attorney-in-Fact for Christopher Bernander  
**Date:** 2025-12-02

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**